LY22-01c

Main Content

Outcomes of CD19 CAR-T in patients who achieve complete remission prior to lymphodepletion in patients with aggressive non-Hodgkins lymphoma.

Study #: LY22-01c

Study Status: Published

Presentation(s)

2023, ASH (Oral)

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: A Center for International Blood and Marrow Transplant Research analysis.

Citation

Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A.

Leukemia. 2024, Jul 01: 38(7): 38(7):1564-1569. doi: 10.1038/s41375-024-02242-6. Epub 2024, May 15. PMCID:PMC11271761.

PubMed

PMID: 38750138

Abstract